Brief: Morphosys Preliminary Q3 Monjuvi U.S. Sales At $22.2 Mln

Morphosys AG

21/10/2022 10:42

Oct 21 (Reuters) - MORPHOSYS AG  MORG.DE :
    * MORPHOSYS AG REPORTS PRELIMINARY Q3 2022 MONJUVI U.S.
SALES AND
UPDATES FINANCIAL GUIDANCE FOR 2022
    * PRELIMINARY Q3 2022 MONJUVI U.S. NET PRODUCT SALES OF US$
22.2
MILLION (EUR 21.9 MILLION)
    * ANTICIPATE FULL YEAR 2022 MONJUVI U.S. NET PRODUCT SALES
TO BE
APPROXIMATELY US$ 90 MILLION

Source text for Eikon:  ID:nEQbfm7hba 
Further company coverage:  MORG.DE 
 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))